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a  b  s  t  r  a  c  t
Based  on  the  increasing  number  of  multi-drug  resistant  bacteria  in  periprosthetic  infections,
improvement  of  the  antibacterial  activity  of commonly  used  biomaterials  must  be achieved.
The broad-spectrum,  high  antimicrobial  efﬁcacy  has  made  silver  nanoparticles  a  promising
new antibacterial  agent.  However,  there  is still  a serious  lack of knowledge  concerning  the
impact of  nanosilver  on bone cells.
For this  reason  a  study  was  conducted  to  evaluate  the  inﬂuence  of silver  nanoparticles
on  osteoclastogenesis  of  human  peripheral  blood  mononuclear  cells.  Upon  incubation  with
subtoxic concentrations  of  nanosilver  the  cells  did  not  exhibit  changes  in osteoclast  dif-
ferentiation  and  podosomal  structures.  However,  the  osteoclasts  were  able  to  uptake  the
nanoparticles,  accumulating  them  in  endo-lysosomal  compartments.  Furthermore,  nanosil-
ver exposure  led to an increase  in  oxidative  stress  and  a decrease  in  clathrin-dependent
endocytosis  on  the  mRNA  level.
In conclusion,  our  results  indicate  nanosilver-induced  cell  stress  at higher  concentrations.
For  this  reason  antibacterial  beneﬁts  and  possible  health  risks  should  be weighed  in  more
detail  in further  studies.
© 2014  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under  the CC
Y-NC-NB
1. Introduction
Bone tissue is a highly dynamic part of the endoskele-
ton comprised of a difﬁcile interplay of bone formation and
resorption.  One key player in that sophisticated remodeling
process are osteoblasts, which derive from mesenchymal
stem cells and produce collagen as well as hydroxy-
apatite crystals, forming the extracellular bone matrix
[1,2]. The second key player are osteoclasts, which evolve
from  hematopoietic stem cells and are able to dissolve
the organic as well as the inorganic compounds of the
bone  matrix by release of hydrogen ions and proteases,
∗ Corresponding author. Tel.: +49 641 9939870; fax: +49 641 9939879.
E-mail address: Katrin.S.Lips@chiru.med.uni-giessen.de (K.S. Lips).
http://dx.doi.org/10.1016/j.toxrep.2014.10.012
2214-7500/© 2014 Published by Elsevier Ireland Ltd. This is an open access
licenses/by-nc-nd/3.0/).D license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
like cathepsin K [3,4]. The activated, mature osteoclasts
appear as multinucleated, polarized cells that exhibit adhe-
sion  structures called podosomes [5]. These podosomes
are a prerequisite for sealing zone formation, marking
the establishment of the rufﬂed border and therefore
bone resorption [6,7]. Only if balance is found between
osteoblast and osteoclast activity, healthy bone structures
and  successful anchorage of implants can be achieved.
Bacterial colonization of implant surfaces is a com-
mon  incidence in surgery and orthopedics and poses a
devastating situation for the patient [8–10]. Treatment
of periprosthetic infections proves to be difﬁcult due to
bioﬁlm  formation that protects the sessile bacteria against
antimicrobial agents and the immune defense [11]. An
already  existing bioﬁlm is highly stable and extremely dif-
ﬁcult  to eradicate, why  bacterial adhesion and therefore
 article under the CC BY-NC-ND license (http://creativecommons.org/
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ioﬁlm formation has to be inhibited in the ﬁrst place.
ince the majority of implant-associated infections are
aused  by gram positive staphylococci [11], aminoglyco-
ides like gentamicin have become a popular preventive
dditive for biomaterials [12]. However, in the last decades
n  increase of infections caused by multi-drug resistant
rganisms (MDRO) can be observed [11]. This circumstance
equires the design of non-conventional antibiotics for
nfectionprophylaxis that allow broad spectrum efﬁcacy,
ncluding MDRO. Silver nanoparticles (AgNPs) have been
emonstrated to assure high antimicrobial efﬁcacy while
evealing low cytotoxicity [13–16]. Due to the versatile
echanisms of bacterial inhibition, including disruption of
acterial  membrane, interference with energy production
nd  inhibition of replication, silver-resistance cannot easily
e  gained [17–19].
However, the potential use of silver nanoparticles for
edical applications demands the thorough investigation
f  cellular interaction with the material. Therefore, a study
as  conducted to examine the interaction of pure AgNPs
ith  human osteoclasts. Additionally, cellular uptake and
ntracellular distribution of nanosilver were studied.
.  Methods
.1. Nanoparticles and nanoparticle characterization
The AgNPs were provided by ras materials GmbH
Regensburg, Germany). The nanoparticles are embed-
ed  in an aqueous stabilizing matrix composed of 4%
olyoxyethylene glycerol trioleate (PGT) and 4% poly-
xyethylene sorbitan monolaurate (Tween20), exhibiting a
ominal  silver content of 10 w/w%. Pure stabilizing matrix
as  included into the experiments as an internal control
o  distinguish between matrix-induced and nanoparticles-
nduced alterations. All stock solutions were prepared by
ilution  in sterile deionized water. The stocks were further
iluted  in cell medium to achieve the ﬁnal concentrations
or the experiments. All samples were kept in the dark to
void  light-induced reduction of silver. Medium without
est  substance supplement served as a negative control.
The  hydrodynamic diameter and the zeta potential
f 20 g/g AgNPs diluted in cell medium or deionized
ater were determined by conducting Dynamic Light Scat-
ering  with a Malvern Zetasizer Nano Range (Malvern
nstruments GmbH, Herrenberg, Germany) at 25 ◦C and
n  excitation of 633 nm.  To deﬁne the agglomeration
ehavior of the AgNPs in the corresponding cell medium
V–vis spectrometry was applied. Therefore, 20 g/g
gNPs diluted in cell medium or deionized water were
ransferred to a 1 cm cuvette and the UV–vis spectrum was
easured at wavelengths between 350 and 700 nm with
n  8453 UV–vis spectrophotometer (Hewlett-Packard, Palo
lto,  California, USA).
.2.  Cell culturePeripheral blood mononuclear cells (PBMCs) were iso-
ated  from human buffy coats of healthy anonymous
onors. Buffy coats were provided by the blood donation
enter of the Justus-Liebig-University Giessen, Germany.orts 1 (2014) 900–908 901
Cells  from the donors were not pooled. Lymphocytes
and monocytes were separated from the blood by den-
sity  gradient centrifugation based on Ficoll (LeucoSep,
greiner bio-one, Frickenhausen, Germany). Subsequently,
10.5 × 105 PBMCs per cm2 were seeded into 24-well plates
and  incubated with DMEM high glucose including 10%
fetal  calf serum, 100 U/ml penicillin, 100 g/g streptomycin
and 25 ng/ml macrophage-colony stimulating factor (M-
CSF)  (Sigma-Aldrich Chemie GmbH, Steinheim, Germany).
To  induce osteoclastogenesis, 25 ng/ml receptor activator
of  NFB ligand (RANKL) (Santa Cruz Biotechnology, Santa
Cruz,  CA, USA), 1 ng/ml transforming growth factor-1
(TGF-1) (Sigma-Aldrich) and small pieces of calf bone
slices were given to the monocytes after 72 h. Additionally,
the corresponding amount of AgNPs was given to the cells.
The  cells were incubated at 37 ◦C and 6% CO2 and the osteo-
clast  medium, including the AgNPs, was  changed twice per
week.
2.3.  Cell morphology and adhesion
After 8, 18 and 28 days changes in outer cell morphology
were determined using a Leica microscope TYPE 090-
135.002 (Leica Microsystems GmbH, Wetzlar, Germany)
equipped with a Nikon Ds-Fi1 digital camera (Nikon,
Duesseldorf, Germany). Concentrations above 3000 ng/g
nanosilver revealed strong cytotoxicity indicated by cell
death.  Therefore, sublethal concentration of ≤3000 ng/g
nanosilver were used in the following experiments.
Additionally, cell morphology was examined by ﬂuores-
cence  microscopy. Therefore, PBMCs were incubated with
1000  ng/g AgNPs for 8, 18 and 28 days. Subsequently, the
samples were ﬁxed with 4% paraformaldehyde in PBS, pH
7.3,  for 10 min. Permeabilization was achieved by incu-
bation  with 0.1% triton X-100 in PBS for 5 min. F-actin
was stained with 5 g/ml phalloidin-TRITC (Sigma-Aldrich
Chemie GmbH) for 40 min  in the dark, followed by DNA
staining with 2 g/ml DAPI (Roth, Karlsruhe, Germany) for
15  min  in the dark. Finally, the samples were mounted
on glass coverslips and kept at 4 ◦C. Analysis was  done
using a confocal laser scanning microscope (TCS SP5, Leica
Microsystems GmbH).
2.4.  Time-of-ﬂight secondary ion mass spectrometry
Cellular uptake of AgNPs was determined conducting
Time of Flight-Secondary Ion Mass Spectrometry (ToF-
SIMS). Therefore, PBMCs were seeded on silicon wavers
(Silicon Materials, Kaufering, Germany) and incubated with
1000  ng/g AgNPs. After 28 days, the medium was  discarded
and  the cell layer was ﬁxed for 30 min at 4 ◦C with 2%
paraformaldehyde in 0.1 M sodium phosphate buffer (pH
7.2–7.4)  containing 2% glutardialdehyde and 0.02% picric
acid.  Samples were kept in the dark at 4 ◦C for further anal-
ysis  with a TOF.SIMS 5-100 instrument (ION-TOF GmbH,
Muenster, Germany). The instrument is equipped with a
25  keV Bi-cluster primary ion gun and a 10 keV C60 gun for
sputtering. Further experimental details are given in [20].
Data  analysis was  done using the software “SurfaceLab 6.3”
(ION-TOF  GmbH).
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2.5. Transmission electron microscopy
To deﬁne the destination of the nanoparticles inside
the cell, PBMCs were incubated with 1000 ng/g AgNPs for
28  days. Subsequently, the cells were ﬁxed for 30 min  on
ice  with 2% paraformaldehyde in 0.1 M sodium phosphate
buffer (pH 7.2–7.4) with 2% glutardialdehyde and 0.02%
picric acid, followed by a 20 min  ﬁxation with 1% osmium
tetroxide in 0.1 M sodium cacodylate buffer (pH 7.2–7.4).
The  samples were dehydrated and embedded in epon, an
epoxy  resin. Ultrathin cuts were prepared and applied to
collodion  coated copper grids. Examination was done using
a  LEO 912 transmission electron microscope (Carl Zeiss AG,
Oberkochen, Germany) equipped with a Slow Scan Dual
Speed  CCD camera TRS Sharpeye (Albert Troendle Proto-
typentwicklung, Moorenweis, Germany).
2.6. Real time reverse transcription polymerase chain
reaction
Cells incubated with different concentrations of
nanosilver were lyzed after 18 and 28 days, respectively.
RNA was isolated according to the protocol of the RNeasy
Mini  Kit (Qiagen GmbH, Hilden, Germany) and 1000 ng
RNA  was reversely transcribed using the cDNA QuantiTect
Reverse Transcription Kit (Qiagen GmbH). Real time
polymerase chain reaction was conducted applying the
QuantiFast SYBR Green PCR Kit (Qiagen GmbH). All primers
were  purchased from Euroﬁns MWG  Operon (Ebersberg,
Germany) (Table 1). The results were ﬁnally normalized to
the  reference gene beta-2-microglobulin (2MG).
2.7. Statistics
Statistical analysis was done using “SPSS Statistics 20.0”
software (IBM Corporation, Armonk, NY, USA). Experi-
ments were conducted as duplets and repeated ﬁve times.
The  treatment groups were compared to the negative con-
trol  by a Mann–Whitney-U test. The results are expressed
as means ± SD. p ≤ 0.05 was considered to be statistical sig-
niﬁcant.
3.  Results
3.1. Nanoparticle characterization
The  hydrodynamic diameter of at least 95% of the
nanoparticles diluted in osteoclast medium remained con-
stantly  between 5 and 10 nm,  while a small amount
displayed a size distribution of about 20–50 nm (Fig. 1A).
The  zeta potential, a term for the stability of a colloidal
dispersion, was measured to be slightly negative (−6 mV),
therefore indicating a tendency to nanoparticle agglomer-
ation. These results correspond to the behavior of AgNPs
diluted in deionized water [21].
UV–vis analysis revealed a typical surface plasma res-
onance (SPR) peak at about 409 nm,  slightly shifting to a
higher  wavelength with time. Due to particle agglomera-
tion, a second peak is located at 560 nm shifting to about
590  nm at day 7. This was not observed for particles diluted
in  deionized water [21]. Additionally, a time-dependentorts 1 (2014) 900–908
decrease in absorbance as well as broadening of the SPR
peak  was  detected, indicating attachment of medium com-
ponents  to the nanoparticle surface (Fig. 1B).
3.2. Nanoparticle-induced changes in cell morphology
Upon incubation of the PBMCs with different concen-
trations of AgNPs no inhibition of preosteoclast fusion
and  osteoclast differentiation could be detected by light
microscopy. At the early time point of 8 days, mainly
two  different cell types could be distinguished in the
AgNP approach and the negative control: mononucleated,
round-shaped cells and mononucleated, spindle-shaped
cells (Data not shown). After 18 days, a third phenotype
of round-shaped, multinucleated cells appeared, while
the  number of mononucleated cells decreased (Data not
shown).  After 28 days the cell culture was dominated by
large,  multinucleated cells of 100–250 m.  Few osteoclast-
like giant cells with sizes exceeding 400 m were detected
(Fig. 2). The mature osteoclasts incubated with nanoparti-
cles exhibit multiple ﬁlopodia and lamellipodia, while in
the  control the amount of those cytoplasmatic projections
was  reduced (Fig. 2). Additionally, orange coloring was
observed in the peri-nuclear region of cells incubated with
higher  amounts of AgNPs, indicating nanoparticle uptake
(Fig.  2F).
Fluorescence microscopy conﬁrmed former obser-
vations. No inhibition in osteoclastogenesis could be
detected following AgNP exposure. Contrary to the nega-
tive  control, a larger number of ﬁlopodia/lamellipodia was
detected,  especially in the early time points. Three differ-
ent  podosome formations were found in all approaches:
podosome clusters, podosome rings and podosome belts.
Additionally, radial actin structures were visible in the
AgNP  approach and the negative control (Fig. 3). Based on
the  autoﬂuorescence of AgNPs, the nanoparticles appeared
as  green dots in ﬂuorescence microscopy. Already after 8
days  AgNP uptake was visible. The nanoparticles accumu-
lated peri-nuclear. However, the quantity of AgNPs differed
in  the various cell types. Especially, in the larger, multinu-
cleated cells less AgNPs were visible (Fig. 3).
3.3. Cellular uptake of nanoparticles
ToF-SIMS  was  used to perform mass spectrometric
analysis of organic and inorganic components inside the
cells  incubated with 1000 ng/g AgNPs. Analysis revealed
few  amounts of silver on the outer cell membrane upon
addition of AgNPs (Fig. 4A). With ongoing cell abrasion
there is an increase in the signals of the silver isotopes
107Ag and 109Ag (Fig. 4C). In the control no silver could
be detected associated with the membrane or located
inside the cells (Fig. 4B and D). To depict the cells, the
mass signal at m/z = 86.10 u (C5H12N+), a fragment of phos-
phatidylcholine, was chosen. Before abrasion (t = 0 s), a
high  C5H12N+ signal but only low silver count rates were
detected directly on the cell surface. With ongoing cell
abrasion (t = 30 s and t = 550 s), the signals for both silver
isotopes increase. Additionally, the silicon signal is given
to  demonstrate removal of the cells. This silicon signal is
increasing with decrease of the cell signal (Fig. 5).
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Table 1
Listing of primers used to examine changes in osteoclast gene expression.
Gene Role Forward primer (5′–3′) Reverse primer (3′–5′)
2MG (NM 004048) Reference TCTCTCTTTCTGGCCTGGAG CAACTTCAATGTCGGATGGA
CtsK (NM 000396.3) Differentiation TTCCGCAATCCCGATGGAATA GCAAAGCTCACCACAGGTAG
PICALM (NM 001206946.1) Endocytosis ATTTTCTACCCCTAGTTCTTC AGTAGCAGAGAAAGGATCTC
Nqo1 (NM 000903.2) Oxidative stress AGCTGGAAGCCGCAGACCTTG TGAACACTCGCTCAAACCAGCC
ACCC
 nositol b
1
a
n
e
t
s
n
i
r
F
(
F
f
aCHOP (NM 001195053.1) ER stress 
2MG  = beta-2-microglobulin, CtsK = cathepsin K, PICALM = phosphatidyli
,  CHOP = C/EBP homologous protein.
Transmission electron microscopy revealed cellular
ccumulation of AgNPs in larger quantities (Fig. 6A). The
anoparticles taken up by the osteoclasts are found inside
ndo-lysosomal structures, appearing as single nanopar-
icles or smaller clusters (Fig. 6B and C). Despite their
mall size, no nanoparticles could be found inside the
ucleus (Fig. 6D). Additionally, no AgNPs were present
nside organelles, like mitochondria or the endoplasmatic
eticulum (ER) (Fig. 6E and F). According to ToF-SIMS,
ig. 1. Characterization of 20 g/g AgNPs diluted in osteoclast medium. (A) A
B)  Nanoparticle agglomeration was examined by UV–vis spectrometry.
ig. 2. Morphological observation using inverted light microscopy. PBMCs w
or  28 days. (A) Cells without nanoparticle supplementation served as a negative
rrows  indicate ﬁlopodia and lamellipodia.TGCTTCTCTGGCTTGGC GGAGAGTGAGGCCTCTGGGAG
inding clathrin assembly protein, Nqo1 = NADPH quinone oxidoreductase
few nanoparticles were detected on the cell mem-
brane, partly enclosed in vesicles (Fig. 6G). Furthermore,
phagosome/pinosome-like structures could be observed
inside the cells incubated with AgNPs (Fig. 6H).3.4. Nanoparticle-induced changes in gene expression
Incubation with AgNPs during osteoclast differentia-
tion left cathepsin K mRNA level unchanged for 18 days
gNP size distribution was  obtained by applying dynamic light scattering.
ere incubated with (B) 300 ng/g, (D) 1000 ng/g and (E) 3000 ng/g AgNPs
 control. (C) and (F) Magniﬁed section of (B) and (E), respectively. White
904 L. Pauksch et al. / Toxicology Reports 1 (2014) 900–908
scence 
rol. Oste
odosomFig. 3. Cell morphology and nanoparticle uptake determined by ﬂuore
days,  while cells without AgNP supplementation served as a negative cont
rings  (closed arrow), radial actin arrangements (short, open arrow) and p
but led to a slight, not signiﬁcant, decrease after 28 days.
Additionally, a not signiﬁcant increase in Nqo1, a marker
for  oxidative stress, could be observed for all tested con-
centrations. After 28 days Nqo1 levels were signiﬁcantly
elevated for the highest AgNP concentration. In contrast,
no  changes in ER stress, displayed by the marker CHOP,
were detected at any time point. Furthermore, PICALM,
a  marker for clathrin-dependent endocytosis, was  sig-
niﬁcantly decreased after 28 days upon incubation with
1000  ng/g and 3000 ng/g AgNPs (Fig. 7).
No changes in gene expression were observed following
incubation with the stabilizing matrix w/o AgNPs (data not
shown).
4.  Discussion
The increasing number of MDRO in biomaterial-
associated infections necessitates the development of new
antibacterial agents. In the present study we evaluated
the cytocompatibility of silver nanoparticles toward osteo-
clasts.  Albers et al. [22] demonstrated impairment of
primary mouse osteoclast viability and differentiation at
a  concentration ≥128 g/ml after 72 h. At sublethal con-
centrations stimulation of cell viability and differentiationmicroscopy. PBMCs were incubated with 1000 ng/g AgNPs for 8, 18 or 28
oclasts showed formation of podosome clusters (open arrow), podosome
e belts (short, closed arrow).
capacity was  observed. These ﬁndings could not be con-
ﬁrmed  in our study.
Our  results indicate no inﬂuence on osteoclastogenesis
upon incubation of PBMCs with sublethal concentrations of
AgNPs.  The cells revealed no signiﬁcantly changed mRNA
levels  of cathepsin K and displayed unaltered morphology
as well as podosomal structures as described by Jurdic et al.
[5].  Interestingly, additional radial actin structures could
be  observed in the mature osteoclasts of all approaches.
Such actin arrangements have been described before by
Takito  et al. as zipper-like structures [23]. The author
explains two different mechanisms of podosome belt for-
mation  in osteoclasts: On one hand, podosomal clusters
become apparent after mononuclear cell fusion, which
develop to actin rings and ﬁnally to a podosome belt. On
the  other hand, mononuclear cells with actin rings fuse
to  form large syncytia with zipper-like structures. These
radial  actin arrangements further break down leaving a
podosome belt. The ﬁrst mechanism has been described
to  form smaller osteoclasts, while the second mechanism
can generate very large osteoclasts with more nuclei. Both
mechanisms were observed in our cell culture approaches,
which might explain the wide osteoclast size distribution.
A  high number of ﬁlopodia/lamellipodia was  vis-
ible on the osteoclast surface upon incubation with
L. Pauksch et al. / Toxicology Reports 1 (2014) 900–908 905
Fig. 4. Nanoparticle uptake determined by time of ﬂight-secondary ion mass spectrometry. Osteoclasts were incubated with 1000 ng/g AgNPs for 28
days.  Mass spectra of the cell surface (A) with AgNPs and (B) without AgNPs. Mass spectra of the cell interior. (C) with AgNPs and (D) without AgNPs.
Fig. 5. Mass images obtained from time-of-ﬂight secondary ion mass spectrometry. Osteoclasts were incubated with 1000 ng/g AgNPs for 28 days. The
mass  signals C5H12N+, Si+ and 107Ag+ + 109Ag+ are displayed in dependence of the sputter time. t = 0 s is a surface image and t = 550 shows the ﬁnal situation
after nearly complete removal of the cell. In the right column the starting and the ﬁnal image of the internal video camera are depicted.
906 L. Pauksch et al. / Toxicology Reports 1 (2014) 900–908
 electro
omal str
some-lFig. 6. Cellular distribution of nanoparticles examined by transmission
with  1000 ng/g AgNPs for 28 days. (B) AgNPs entrapped inside endo-lysos
organelles.  (G and H) AgNPs detected inside vesicles and phagosome/pino
nanoparticles. Filopodia/lamellipodia presence in combi-
nation  with podosomal structures is a known characteristic
for osteoclasts seeded on nonosteoid materials [24]. Filopo-
dia  are thin membrane protrusions comprised of parallel
bundles of ﬁlamentous actin, which are involved in a
Fig. 7. mRNA expression of speciﬁc osteoclast cell markers. Cells were incub
were  compared to the negative control without AgNPs (broken line). * p ≤ 0.05.n microscopy. (A) Nanoparticle distribution inside osteoclasts incubated
uctures. (C) Higher magniﬁcation of (B). (D–F) Absence of particles inside
ike structures.
number  of cellular processes, like cellular migration and
adhesion [25]. Because less ﬁlopodia were seen on osteo-
clasts  not exposed to AgNPs, additional ﬁlopodial function
must  be assumed. In macrophages involvement of ﬁlopodia
in  particle uptake has been repeatedly described [26–28].
ated with different concentrations of AgNPs for 18 and 28 days. Results
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ince nanoparticle accumulation inside osteoclasts could
e  conﬁrmed in the present study, ﬁlopodial and lamel-
ipodial involvement in particle uptake is plausible.
AgNPs uptaken by the cells end up in endo-lysosomal
tructures, but not in the cytosol or in organelles. However,
ononucleated or small, multinucleated cells revealed a
igher  degree of AgNP accumulation than large, multi-
ucleated osteoclasts. Mature osteoclasts possess a high
ranscytose activity that might lead to removal of uptaken
anoparticles [29]. This mechanism of AgNP removal by
levated  transcytosis activity, could also explain the sig-
iﬁcantly reduced mRNA levels in clathrin-dependent
ndocytosis upon incubation with AgNPs. Corisdeo et al.
emonstrated induction of cathepsin K mRNA expression
y  RANKL, which is endocytosed by a clathrin-dependent
athway [30,31]. Therefore the reduced levels of PICALM
ight lead to the slight decrease in cathepsin K mRNA
xpression observed after incubation with AgNPs for 28
ays.
In  a previous study we have described the same
ndo-lysosomal accumulation pattern for AgNPs in mes-
nchymal stem cells and osteoblasts, ﬁnally leading to
xidative stress, ER stress and cell death [21]. Also in
he  present study nanoparticle supplementation led to
nduction of oxidative stress on the mRNA level. However,
o  nanoparticles could be detected inside mitochondria
r the ER, which implies that silver ions released from
he  particles translocate into the organelles interfering
ith mitochondrial and ER function. Interestingly, ER
tress,  indicated by the CHOP marker, was not induced
ut down-regulated during AgNP exposure. These ﬁnd-
ngs  were unexpected and have to be investigated in
urther studies. Regarding long-time exposure, this time-
ependent increase in oxidative stress combined with
ontinuous cellular nanoparticle uptake might lead to
eduction of the lethal concentration and to an increase
n  cellular toxicity over time. However, for medical
pplication nanosilver will be ﬁrmly attached to the appro-
riate  biomaterial preventing cellular nanoparticle uptake.
dditionally, the in vivo system will ensure a steady
ow of ﬂuids reducing the local accumulation of sil-
er  nanoparticles and therefore possibly increasing the
iocompatibility.
.  Conclusion
In  conclusion, it can be stated that nanosilver exposure
t sublethal concentrations does not induce alterations in
steoclastogenesis. However, in vitro testing led to accu-
ulation of AgNPs and induction of the reactive oxygen
pecies production. Therefore, further studies are needed
o  weigh the antibacterial beneﬁt and the potential health
isks  of AgNPs.ransparency document
The  Transparency document associated with this article
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[orts 1 (2014) 900–908 907
Acknowledgements
The authors would like to thank Stefﬁ Weghenkel,
Ivonne Bergen and Iris Schütz for their technical assistance.
Our  special thanks go to ras materials GmbH, Regensburg,
Germany for providing us with the nanosilver colloidal dis-
persion.
This  work was ﬁnancially supported by the Federal Min-
istry  of Education and Research [03X0103D].
References
[1] L.D. Quarles, D.A. Yohay, L.W. Lever, R. Caton, R.J. Wenstrup, Distinct
proliferative and differentiated stages of murine MC3T3-E1 cells in
culture:  an in vitro model of osteoblast development, J. Bone Miner.
Res.  7 (1992) 683–692.
[2] M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D.
Mosca,  M.A. Moorman, D.W. Simonetti, S. Craig, D.R. Marshak, Mul-
tilineage  potential of adult human mesenchymal stem cells, Science
284  (1999) 143–147.
[3] G. Vaes, Cellular biology and biochemical mechanism of bone resorp-
tion.  A review of recent developments on the formation, activation,
and mode of action of osteoclasts, Clin. Orthop. Relat. Res. 231 (1988)
239–271.
[4] D.S. Yamashita, R.A. Dodds, Cathepsin K and the design of inhibitors
of  cathepsin K, Curr Pharm Des 6 (2000) 1–24.
[5]  P. Jurdic, F. Saltel, A. Chabadel, O. Destaing, Podosome and sealing
zone: speciﬁcity of the osteoclast model, Eur. J. Cell Biol. 85 (2006)
195–202.
[6]  H.K. Väänänen, H. Zhao, M. Mulari, J.M. Halleen, The cell biology of
osteoclast function, J. Cell. Sci. 113 (2000) 377–381.
[7]  C. Luxenburg, D. Geblinger, E. Klein, K. Anderson, D. Hanein, B. Geiger,
L.  Addadi, The architecture of the adhesive apparatus of cultured
osteoclasts: from podosome formation to sealing zone assembly,
PLoS One 2 (2007) e179.
[8] R. Lentino, Prosthetic joint infections: bane of orthopedists, chal-
lenge  for infectious disease specialists, Clin. Infect. Dis. 36 (2003)
1157–1161.
[9]  S.M. Jafari, C. Coyle, S.M. Mortazavi, P.F. Sharkey, J. Parvizi, Revision
hip  arthroplasty: infection is the most common cause of failure, Clin.
Orthop.  Relat. Res. 468 (2010) 2046–2051.
10]  A. Renaud, M. Lavigne, P.A. Vendittoli, Periprosthetic joint infections
at  a teaching hospital in 1990–2007, Can. J. Surg. 55 (2012) 394–400.
11]  D. Campoccia, L. Montanaro, C.R. Arciola, The signiﬁcance of infec-
tion  related to orthopedic devices and issues of antibiotic resistance,
Biomaterials 27 (2006) 2331–2339.
12] Y. Chang, C.L. Tai, P.H. Hsieh, S.W.N. Ueng, Gentamicin in bone
cement: a potentially more effective prophylactic measure of infec-
tion  in joint arthroplasty, Bone Joint Res. 2 (2013) 220–226.
13] K.H. Cho, J.E. Park, T. Osaka, S.G. Park, The study of antimicrobial activ-
ity  and preservative effects of nanosilver ingredient, Electrochim.
Acta 51 (2005) 956–960.
14] J.S. Kim, E. Kuk, K.N. Yu, J.H. Kim, S.J. Park, H.J. Lee, S.H. Kim, Y.K.
Park,  Y.H. Park, C.Y. Hwang, Y.K. Kim, Y.S. Lee, D.H. Jeong, M.H. Cho,
Antimicrobial effects of silver nanoparticles, Nanomedicine 3 (2007)
95–101.
15]  P.V. AshaRani, G. Low Kah Mun, M.P. Hande, S. Valiyaveettil, Cyto-
toxicity and genotoxicity of silver nanoparticles in human cells, ACS
Nano  3 (2009) 279–290.
16] F. Martinez-Gutierrez, P.L. Olive, A. Banuelos, E. Orrantia, N. Nino,
E.M.  Sanchez, F. Ruiz, H. Bach, Y. Av-Gay, Synthesis, characteriza-
tion, and evaluation of antimicrobial and cytotoxic effect of silver
and  titanium nanoparticles, Nanomedicine 6 (2010) 681L 688.
17] Q.L. Feng, J. Wu,  G.Q. Chen, F.Z. Cui, T.N. Kim, J.O. Kim, A mechanistic
study of the antibacterial effect of silver ions on Escherichia coli and
Staphylococcus aureus, J. Biomed. Mater. Res. 52 (2000) 662–668.
18] I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial
agent: a case study on E. coli as a model for Gram-negative bacteria,
J.  Colloid Interface Sci. 275 (2004) 177–182.
19]  J.R. Morones, The bactericidal effect of silver nanoparticles, Nano-
technology 16 (2005) 2346–2353.
20] J. Kokesch-Himmelreich, M.  Schumacher, M. Rohnke, M.  Gelinsky,
J.  Janek, ToF-SIMS analysis of osteoblast-like cells and their min-
eralized extracellular matrix on strontium enriched bone cements,
Biointerphases 8 (2013) 17.
logy Rep
[
[
[
[
[
[
[
[
[
[
clasts, Eur. J. Histochem. 54 (2010) e6.908 L. Pauksch et al. / Toxico
21] L. Pauksch, S. Hartmann, M.  Rohnke, G. Szalay, V. Alt, R. Schnettler,
K.S. Lips, Biocompatibility of silver nanoparticles and silver ions in
primary  human mesenchymal stem cells and osteoblasts, Acta Bio-
mater.  10 (2014) 439–449.
22] C. Albers, W.  Hofstetter, K.A. Siebenrock, R. Landmann, F.M. Klenke,
In  vitro cytotoxicity of silver nanoparticles on osteoblasts and
osteoclasts at antibacterial concentrations, Nanotoxicology 7 (2011)
30–36.
23]  J. Takito, M.  Nakamura, M.  Yoda, T. Tohmonda, S. Uchikawa, K. Hori-
uchi,  Y. Toyama, K. Chiba, The transient appearance of zipper-like
actin superstructures during the fusion of osteoclasts, J. Cell. Sci. 125
(2012)  662–672.
24] F. Saltel, O. Destaing, F. Bard, D. Eichert, P. Jurdic, Apatite-mediated
actin dynamics in resorbing osteoclasts, Mol. Biol. Cell 15 (2004)
5231–5241.
25] P.K. Mattila, P. Lappalainen, Filopodia: molecular architecture and
cellular  functions, Nat. Rev. Mol. Cell Biol. 9 (2008) 446–454.
26] H. Kress, E.H. Stelzer, D. Holzer, F. Buss, G. Grifﬁths, A. Rohrbach,
Filopodia act as phagocytic tentacles and pull with discrete steps
[orts 1 (2014) 900–908
and a load-dependent velocity, Proc. Natl. Acad. Sci. U.S.A. 104 (2007)
11633–11638.
27]  J. Möller, T. Lühmann, M.  Chabria, H. Hall, V. Vogel, Macrophages
lift off surface-bound bacteria using a ﬁlopodium-lamellipodium
hook-and-shovel mechanism, Sci. Rep. 3 (2013) 2884.
28] L. Vonna, A. Wiedemann, M.  Aepfelbacher, E. Sackmann, Microme-
chanics of ﬁlopodia mediated capture of pathogens by macrophages,
Eur. Biophys. J. 36 (2007) 145–151.
29] H. Zhao, Membrane trafﬁcking in osteoblasts and osteoclasts: new
avenues  for understanding and treating skeletal diseases, Trafﬁc 13
(2012)  1307–1314.
30] P. Narducci, R. Bortul, R. Bareggi, V. Nicolin, Clathrin-dependent
endocytosis of membrane-bound RANKL in differentiated osteo-31]  S. Corisdeo, M.  Gyda, M.  Zaidi, B.S. Moonga, B.R. Troen, New
insights into the regulation of cathepsin K gene expression by osteo-
protegerin ligand, Biochem. Biophys. Res. Commun. 285 (2001)
335–339.
